Efficacy of newer medications for treating depression in primary care patients

Medicine and Dentistry

• Patient 70%
• Primary Health Care 60%
• Depression 50%
• Antidepressant 30%
• Medication 30%
• Adverse Event 20%
• Therapeutic Procedure 20%
• Adult 20%
• Serotonin 10%
• Combination Therapy 10%
• Noradrenalin 10%
• Dysthymia 10%
• Neurosis 10%
• Major Depressive Episode 10%
• Selective Serotonin Reuptake Inhibitor 10%
• Mixed Anxiety and Depression 10%
• Amine Oxidase (Flavin Containing) 10%
• Anxiety 10%
• Consultation 10%

Neuroscience

• Antidepressant 60%
• Treatment of Depression 60%
• Depression 50%
• Placebo 50%
• Randomized Controlled Trial 20%
• Adverse Effect 20%
• Severe Depression 20%
• Norepinephrine 10%
• Major Depressive Disorder 10%
• Serotonin 10%
• Neuroticism 10%
• Selective Serotonin Reuptake Inhibitor 10%
• Dysthymia 10%
• Monoamine Oxidase 10%
• Mixed Anxiety and Depression 10%
• Reversible Inhibitor 10%
• Anxiety 10%
• Comorbidity 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo 100%
• Depression 50%
• Randomized Controlled Trial 40%
• Adverse Event 20%
• Clinical Trial 20%
• Serotonin 10%
• Noradrenalin 10%
• Major Depression 10%
• Selective Serotonin Reuptake Inhibitor 10%
• Comorbidity 10%
• Dopamine Receptor Blocking Agent 10%
• Amine Oxidase (Flavin Containing) 10%
• Dysthymia 10%
• Neurosis 10%
• Mixed Anxiety and Depression 10%